Navigation Links
Neural ID Enables Auditing and Analysis of Biosignal Data Directly from the TIBCO Spotfire® Powerful Data Visualization Platform for PerkinElmer’s Life Sciences Customers
Date:8/5/2014

Redwood City, CA (PRWEB) August 05, 2014

Neural ID, the provider of the only enterprise biosignal analytics platform spanning the pharmaceutical lifecycle, today announced that Neural ID’s Intelligent Waveform Service (IWS) will be compatible with the TIBCO Spotfire® platform, thereby enabling PerkinElmer’s TIBCO Spotfire® platform users to interact directly with biosignal traces across Discovery and Preclinical R&D phases (GLP).

“Neural ID’s IWS expert-driven machine learning templates enable a whole new user experience, driving down cost and reducing time to analysis by a factor of ten with our pharmaceutical customers. The Neural ID IWS platform offers new interactive tools and a scalable pattern based approach that is resonating from the bench to the BI analyst,” said Tim Carruthers, CEO of Neural ID. “Neural ID has built a reputation among researchers by enabling them to interact with individual biosignals, helping researchers make better decisions faster.”

“The volume and diversity of data that scientists need to capture and analyze to make knowledgeable and informed decisions is an immense challenge. A researcher’s ability to process vast amounts of complex data from a multitude of sources affects their ability to positively impact both research and business intelligence efforts,” said, Karen Madden, President of Informatics at PerkinElmer. “The addition of this interoperability between the TIBCO Spotfire® platform and Neural ID’s IWS platform capabilities will enable our TIBCO Spotfire® platform customers to leverage an enterprise-class biosignal analytics platform to address scientists’ data processing challenges.”

Neural ID's IWS platform leverages human expertise via machine learning to automate biosignal recognition and analysis from multiple instrument platforms, improving drug research and development by addressing the critical issues of risk management, cost containment and time to market.

The TIBCO Spotfire® platform is a dynamic, collaborative interface that assimilates data from multiple sources including chemical structures, text, numbers, images, chemical properties and biological assays, and empowers users to perform complex analyses and create easy-to-use visual dashboards.

About Neural ID
Neural ID provides the only collaborative biosignal analytics platform spanning the pharmaceutical lifecycle. From Discovery through Clinical and Health Information, Neural ID delivers a scalable enterprise solution addressing the industry’s productivity crisis. Our flagship product, Intelligent Waveform Solution delivers expert-driven machine learning, massive data reduction and an interoperable data format to help customers make better decisions faster, leading to increased product revenues and reduced development costs.    Neural ID, based in Redwood City, CA, launched IWS in 2013. Further information is available at http://www.neuralid.com

Read the full story at http://www.prweb.com/releases/2014/08/prweb12070970.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Neuralstem President And CEO To Present 2014 Trials Overview At 2014 Biotech Showcase
2. Neural prosthesis restores behavior after brain injury
3. Strategic Development of Neural Stem & Progenitor Cell Products
4. Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update
5. Neuralstem President And CEO To Present At The 2013 Rodman & Renshaw Annual Healthcare Conference
6. Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update
7. Gene Therapy Developed for ALS Treatment: New Biotech Company Neuralgene Enters Evaluation Phase
8. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
9. A gut feeling about neural stem cells
10. ENDECE Neural to Present Findings at 2013 Biotech Showcase on NDC-1308 which Induces Remyelination of Demyelinated Axons
11. First Neurally Controlled, Powered Prosthetic Limb Is 2,109 Steps Closer To Realization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)...  Perkotek an innovation leader in attendance control systems is proud to announce the ... employers to make sure the right employees are actually signing in, and to even ... ... ... ...
Breaking Biology News(10 mins):